Metaplanet
3350
Nissan Motor
7201
Shin-Etsu Chemical
4063
4
Nidec
6594
5
Advantest
6857
(Q3)Dec 31, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 5.94%128.81B | 7.92%125.41B | 11.46%477.6B | 8.48%117.12B | 12.66%121.59B | 12.37%122.67B | 12.36%116.21B | 7.97%428.49B | 11.79%107.96B | 2.42%107.93B |
Cost of revenue | 5.80%101.3B | 6.07%388.55B | 9.73%105.22B | 4.41%95.74B | -0.98%366.31B | 1.94%95.89B | -4.96%91.69B | |||
Gross profit | 6.43%27.52B | 43.20%89.05B | -1.41%11.9B | 59.24%25.86B | 130.97%62.18B | 381.84%12.07B | 82.40%16.24B | |||
Operating expense | 11.90%10.88B | 3.81%105.3B | 5.93%40.37B | 31.55%11.17B | 3.62%9.72B | -9.40%-81.96B | 6.60%101.44B | 27.13%38.11B | -14.35%8.49B | 17.35%9.38B |
Staff costs | ---- | ---- | 1.69%18.74B | ---- | ---- | ---- | ---- | -8.63%18.43B | ---- | ---- |
Selling and administrative expenses | ---- | -9.04%8.79B | 12.81%17.14B | 16.13%-12.4B | ---- | ---- | -4.54%9.67B | 9.17%15.2B | 0.80%-14.79B | 132.41%22.73B |
-Selling and marketing expense | ---- | ---- | 12.81%17.14B | ---- | ---- | ---- | ---- | 9.17%15.2B | ---- | ---- |
-General and administrative expense | ---- | -9.04%8.79B | ---- | ---- | ---- | ---- | -4.54%9.67B | ---- | ---- | ---- |
Depreciation and amortization | ---- | ---- | -5.68%3.02B | ---- | ---- | ---- | ---- | 9.99%3.2B | ---- | ---- |
-Depreciation | ---- | ---- | -5.68%3.02B | ---- | ---- | ---- | ---- | 9.99%3.2B | ---- | ---- |
Other operating expenses | ---- | 5.19%96.66B | -24.05%2.43B | ---- | ---- | ---- | 7.25%91.89B | 2.04%3.19B | ---- | ---- |
Total other operating income | ---- | 21.31%148M | -49.56%968M | -60.10%618M | ---- | ---- | -81.35%122M | -81.12%1.92B | 11.20%1.55B | -91.83%146M |
Operating profit | 3.13%16.64B | 36.09%20.11B | 102.20%48.68B | -79.63%729M | 135.33%16.13B | 217.79%17.04B | 78.48%14.78B | 889.12%24.08B | 148.29%3.58B | 655.07%6.86B |
Net non-operating interest income (expenses) | 3.84%-1.81B | 0.79%-1.88B | 1.64%-7.54B | -4.46%-1.88B | -1.96%-1.88B | 5.87%-1.89B | 6.14%-1.89B | 15.49%-7.66B | 17.09%-1.8B | 18.43%-1.84B |
Non-operating interest income | 3,333.33%103M | 366.67%14M | 155.56%23M | 200.00%12M | 50.00%3M | 150.00%5M | 200.00%3M | 50.00%9M | 300.00%4M | 0.00%2M |
Non-operating interest expense | 1.49%1.91B | -0.21%1.89B | -1.46%7.56B | 4.89%1.89B | 2.01%1.88B | -5.72%1.9B | -6.04%1.9B | -15.45%7.67B | -16.94%1.8B | -18.42%1.84B |
Net investment income | 542.86%527M | 37.33%1.44B | 28.68%1.91B | 38.09%823M | 84.01%-119M | -60.57%153M | -15.46%1.05B | -21.79%1.48B | 168.47%596M | -161.79%-744M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -215M | |||||||||
Income from associates and other participating interests | 175.00%27M | 53.85%-30M | -483.33%-70M | 17M | -414.29%-36M | 380.00%14M | -65M | -700.00%-12M | 0 | -250.00%-7M |
Special income (charges) | -82.72%1.1B | 211.51%310M | -98.51%643M | -6.21%-15.52B | -18.74%6.35B | -80.07%10.09B | 47.45%-278M | 10.70%43.29B | -140.33%-14.61B | -38.42%7.81B |
Less:Restructuring and mergern&acquisition | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Less:Impairment of capital assets | ---- | ---- | -53.39%17.28B | ---- | ---- | ---- | ---- | 1,232.35%37.07B | ---- | ---- |
Less:Other special charges | 17.92%-5.23B | -211.91%-310M | 77.70%-17.92B | -80.76%-761M | 24.72%-6.37B | 84.57%-11.06B | 18.38%277M | -91.82%-80.36B | 98.91%-421M | 33.37%-8.47B |
Less:Write off | 15,803.85%4.14B | --0 | ---- | ---- | -96.03%26M | -95.39%972M | -99.66%1M | ---- | ---- | --655M |
Other non-operating income (expenses) | 232.68%1.86B | -17.31%-61M | -97.62%20M | 75.27%-486M | -75.16%560M | -100.37%-2M | -1,400.00%-52M | 900.00%840M | -1,245.89%-1.97B | 255.52%2.25B |
Income before tax | -13.68%18.13B | 46.94%19.89B | -29.62%43.64B | -14.85%-16.31B | 46.60%21.01B | -53.72%25.41B | 93.94%13.54B | 114.03%62.01B | -153.12%-14.2B | 8.78%14.33B |
Income tax | -28.63%3.68B | 0.68%4.32B | 337.80%16.11B | 90.50%-86M | -35.32%5.16B | 205.93%6.75B | 43.59%4.29B | -77.65%3.68B | -113.22%-905M | -9.06%7.97B |
Net income | -8.81%14.45B | 68.40%15.57B | -52.80%27.53B | -22.02%-16.22B | 149.37%15.85B | -69.55%18.66B | 131.61%9.25B | 366.27%58.33B | -166.87%-13.3B | 44.19%6.36B |
Net income continuous operations | -8.81%14.45B | 68.40%15.57B | -52.80%27.53B | -22.02%-16.22B | 149.37%15.85B | -69.55%18.66B | 131.61%9.25B | 366.27%58.33B | -166.87%-13.3B | 44.19%6.36B |
Noncontrolling interests | -13.82%106M | -63.01%54M | -65.76%540M | -105.91%-27M | -75.05%123M | -1.97%298M | -54.80%146M | -16.43%1.58B | 16.88%457M | -6.27%493M |
Net income attributable to the company | -8.77%14.35B | 70.51%15.52B | -52.44%26.99B | -17.77%-16.2B | 168.24%15.73B | -69.89%18.36B | 148.06%9.1B | 434.25%56.75B | -170.55%-13.75B | 50.99%5.86B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -8.77%14.35B | 70.51%15.52B | -52.44%26.99B | -17.77%-16.2B | 168.24%15.73B | -69.89%18.36B | 148.06%9.1B | 434.25%56.75B | -170.55%-13.75B | 50.99%5.86B |
Gross dividend payment | ||||||||||
Basic earnings per share | 8.60%56.68 | 70.52%51.5321 | -52.49%89.65 | -17.67%-53.75 | 169.72%52.19 | -69.93%60.99 | 147.70%30.22 | 433.20%188.7 | -170.34%-45.68 | 49.54%19.35 |
Diluted earnings per share | 8.56%56.66 | 70.52%51.5321 | -52.49%89.62 | -17.74%-53.7906 | 187.76%52.19 | -67.67%60.9782 | 147.70%30.22 | 433.31%188.63 | -175.76%-45.6874 | 50.96%18.1368 |
Dividend per share | 0 | 0 | 0.00%25 | -37.50%12.5 | 0 | 150.00%12.5 | 0 | 400.00%25 | 300.00%20 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |